
Contraceptive Use and the Risk of Ovarian Cancer Among Women With a BRCA1 or BRCA2 Mutation
Women with a BRCA1 and BRCA2 mutation have a higher lifetime risk of developing ovarian cancer.
Each year, WCRF designs, funds, conducts, and publishes numerous clinical studies on the spectrum of women’s cancers. All our gynecologic oncology experts work with the belief that each new clinical trial carries the potential to fundamentally change the future of patients with women’s cancers.
Take a look at how WCRF has contributed to the field of gynecologic oncology.